Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis.

By W. Sandborn, B. Feagan, C. Marano, Hongyan Zhang, R. Strauss, J. Johanns, O. Adedokun, C. Guzzo, J. Colombel, W. Reinisch and 5 more. Gastroenterology, 2014

920 citations recorded by the source corpus.

Subfields: Complementary and alternative medicine, Genetics, Rheumatology

View Paper: https://www.semanticscholar.org/paper/24881e409bf85fd9f36744ddb553131fa0e06c6d